Greetings from the Executive Director
Hitoshi Kato, M.D.,Ph.D.
The hospital of the National Center for Child Health and Development (NCCHD) is the only national hospital to encompass the four areas of pediatric, perinatal, obstetric, and maternal medicine and is also the largest children’s hospital in Japan. In addition, the NCCHD is an academic research organization that combines the National Research Institute for Child Health and Development, which specializes in pediatric and perinatal research, with the Center for Clinical Research and Development. The NCCHD’s mission is to safeguard the health of the next generation and provide the best in advanced medical care to all children and mothers. Our Hospital therefore contains not only departments specializing in pediatric care, but also specialities in psychiatry and obstetrics including departments dedicated to infertility treatment and fetal and maternal medicine. To achieve our goals, we place top priority on medical safety and infection control to ensure safe and high-quality medical care to our patients. Second, we carry out translational research to establish practical ways in which we can use our clinical research findings. Third, we actively provide opportunities to our staff to develop their talents so that they can deliver the best quality of care to our patients. Fourth, we disseminate our research findings to the global medical community.
The NCCHD was selected to be one of the ‘30 Most Technologically Advanced Children’s Hospitals in the World’ in 2016. In this ranking, only six children’s hospitals outside the United States were selected from the total of 30 children’s hospitals; in addition to the NCCHD, two of the non-US institutions chosen were in the UK, one was in Canada, one was in Australia, and one was in Israel. As global recognition of our efforts to provide highly advanced medical care, this award has inspired us to continue to lead the way in both perinatal and pediatric medical care.
In 2019, we established the Center for Gene / Cell Therapy Promotion. Hardware has also been prepared to enable future gene therapy. We will actively promote gene therapy and clinical trials that are delayed compared to the world in cooperation with companies. In addition, it was designated as the only cancer genome base hospital as a pediatric hospital. We must strive from a leadership position to practice pediatric cancer genomics in Japan.
To our center, patients are transported from university hospitals or children's hospitals nationwide at a rate of about one person every two days. The number of second opinion outpatients exceeds 200 per year. Along with name and reality, it became the top and last fort in Japanese pediatric and perinatal care. Having become the premier children’s hospital in Japan, we at the NCCHD are now cementing our position as the flagship children's hospital of Asia. Recently, the number of referral cases from overseas hospitals has begun increasing and it is becoming more and more common for non-Japanese patients to seek inpatient treatment at the NCCHD. In addition, the number of training requests for doctors and nurses from overseas has increased, and last year we accepted 36 training courses.
We hope to keep expanding our connections with hospitals in China, Russia, Southeast Asia, Central Asia, and the Middle East to win a place among the leading children’s hospitals in the world.
Hitoshi Kato, M.D.,Ph.D.